Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapyKris M. Mahadeo, Catherine M. Bollard, Priti Tewari et al.|Nature Reviews Clinical Oncology|2018Cited by 236
Beyond the storm — subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Nirali N. Shah, Juliane Gust et al.|Nature Reviews Clinical Oncology|2021Cited by 68
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trialNavin Pinto, Julie R. Park, Steven G. DuBois et al.|Pediatric Blood & Cancer|2018Cited by 39